Peripheral arterial disease (PAD) is a condition typified by decreased arterial blood flow in the non-coronary branches of the aorta as a result of chronic atherosclerosis. Despite the higher prevalence of PAD compared with other cardiovascular entities such as myocardial infarction and stroke, far less import is given to its diagnosis and treatment. In this review, we highlight principal diagnostic and therapeutic considerations in the management of PAD and its complications. We particularly emphasize the role of clopidogrel in the reduction of risks associated with PAD

J Cavendish, Jeffrey

R Nayak, Keshav

English

PubMed

Keshav R Nayak, Jeffrey J CavendishDepartment of Cardiology, Naval Medical Center San Diego, San Diego, CA, USAAbstract: Peripheral arterial disease (PAD) is a condition typified by decreased arterial blood flow in the non-coronary branches of the aorta as a result of chronic atherosclerosis. Despite the higher prevalence of PAD compared with other cardiovascular entities such as myocardial infarction and stroke, far less import is given to its diagnosis and treatment. In this review, we highlight principal diagnostic and therapeutic considerations in the management of PAD and its complications. We particularly emphasize the role of clopidogrel in the reduction of risks associated with PAD.Keywords: clopidogrel, antiplatelet therapy, peripheral artery diseas

Keshav R Nayak

Jeffrey J Cavendish

Directory of Open Access Journals

Vascular Health and Risk Management

Risk reduction with clopidogrel in the management of peripheral arterial disease

A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE).

ACC/AHA Guidelines for the Management of Patients with Peripheral Artery Disease: Executive Summary.

Addition of clopidogrel to aspirin and ﬁ brinolytic therapy for myocardial infarction with ST-segment elevation.

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease:

Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study.

Atherothrombosis and high-risk plaque. I. Evolving concepts.

Clopidogrel (Plavix) [package insert].

Clopidogrel (Plavix) desensitization protocol. Catheter Cardiovasc Interv,

Clopidogrel and thrombotic thrombocytopenic purpura: no clear case for causality.

Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscler Thromb,

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.

Collaborative metaanalysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a signiﬁ cant risk of bleeding.

Decreased ankle/ brachial indices in relation to morbidity and mortality in patients with peripheral arterial disease. Vasc Med,

Exercise for intermittent claudication. Cochrane Database Syst Rev,

Leg symptoms in peripheral arterial disease. Associated clinical characteristics and functional impairment.

Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic InterSociety Consensus (TASC). J Vasc Surg,

Medical treatment of peripheral arterial disease and claudication.

Mortality over a period of 10 years in patients with peripheral arterial disease.

Platelets in atherothrombosis.

Potentiation of anti-platelet aggregating activity of cilostazol with vascular endothelial cells. Thromb Res,

Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 older women in a longterm health care facility.

Role of antiplatelet therapy in cardiovascular disease III: Peripheral arterial disease. Curr Med Res Opin,

The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med,

The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators.

The global burden of disease,

The prevalence of peripheral arterial disease in a deﬁ ned population.

Thrombotic thrombocytopenic purpura associated with clopidogrel.

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2293969

Risk reduction with clopidogrel in the management of peripheral arterial disease

Abstract

Similar works

Full text

Available Versions

Directory of Open Access Journals